未破裂颅内动脉瘤治疗评分验证:与真实世界脑血管实践的比较
本研究在收治大量未破裂颅内动脉瘤(UIA)患者的高流量四级学术医疗中心,将UIATS推荐与真实世界治疗决策进行对比。3年期间连续纳入221例患者,69例(31%)接受治疗、152例(69%)未治疗。UIATS与治疗显著相关(p < 0.001),但敏感性49%、特异性80%、误分类率28%,ROC曲线下面积0.646。
要点
- 221例UIA患者中,69例(31%)接受治疗,152例(69%)未治疗。
- 59例(27%)UIATS评分在-2至2之间,未给出治疗推荐。
- UIATS推荐治疗的患者中51%未接受治疗,推荐保守管理的患者中20%接受了干预。
核心结论
- 与作者所在中心的经验相比,UIATS推荐了对UIA的过度治疗。
- UIATS可作为筛查工具,但基于与脑血管专家会诊的个体化治疗推荐是必要的。
- 在广泛使用前,需用UIA破裂率的纵向数据进一步验证。
研究设计与样本
- 所有在3年期间评估的UIA患者均被纳入。
- 提取UIATS包含的所有因素,使用UIATS对患者评分。
- 将UIATS推荐与真实世界治疗决策列于列联表进行分类比较。
- 计算误分类百分比、敏感性、特异性和受试者工作特征(ROC)曲线下面积。
- 共221例连续UIA患者符合纳入标准:69例(31%)接受治疗,152例(69%)未治疗。
主要发现
- 59例(27%)患者UIATS评分在-2至2之间,不提供治疗推荐,剩余162例(73%)患者有UIATS治疗推荐。
- UIATS与治疗显著相关(p < 0.001)。
- 敏感性、特异性和误分类百分比分别为49%、80%和28%。
- UIATS推荐治疗的患者中51%在真实世界队列中未接受治疗,UIATS推荐保守管理的患者中20%接受了干预。
- ROC曲线下面积为0.646。
临床怎么用
- 作者认为UIATS可作为筛查工具,但基于与脑血管专家会诊的个体化治疗推荐是必要的。
- 作者认为在广泛使用前需用UIA破裂率的纵向数据进一步验证。
局限性
- 作者指出需用UIA破裂率的纵向数据进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE The purpose of this study was to compare the unruptured intracranial aneurysm treatment score (UIATS) recommendations with the real-world experience in a quaternary academic medical center with a high volume of patients with unruptured intracranial aneurysms (UIAs). METHODS All patients with UIAs evaluated during a 3-year period were included. All factors included in the UIATS were abstracted, and patients were scored using the UIATS. Patients were categorized in a contingency table assessing UIATS recommendation versus real-world treatment decision. The authors calculated the percentage of misclassification, sensitivity, specificity, and area under the receiver operating characteristic (ROC) curve. RESULTS A total of 221 consecutive patients with UIAs met the inclusion criteria: 69 (31%) patients underwent treatment and 152 (69%) did not. Fifty-nine (27%) patients had a UIATS between -2 and 2, which does not offer a treatment recommendation, leaving 162 (73%) patients with a UIATS treatment recommendation. The UIATS was significantly associated with treatment (p < 0.001); however, the sensitivity, specificity, and percentage of misclassification were 49%, 80%, and 28%, respectively. Notably, 51% of patients for whom treatment would be recommended by the UIATS did not undergo treatment in the real-world cohort and 20% of patients for whom conservative management would be recommended by UIATS had intervention. The area under the ROC curve was 0.646. CONCLUSIONS Compared with the authors' experience, the UIATS recommended overtreatment of UIAs. Although the UIATS could be used as a screening tool, individualized treatment recommendations based on consultation with a cerebrovascular specialist are necessary. Further validation with longitudinal data on rupture rates of UIAs is needed before widespread use.
引用
- Ravindra VM, de Havenon A, Gooldy TC, et al. Validation of the unruptured intracranial aneurysm treatment score: comparison with real-world cerebrovascular practice. J Neurosurg. 2017. PMID: 28984518. doi:10.3171/2017.4.JNS17548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。